Literature DB >> 10191428

22q11 deletion in DGS/VCFS monozygotic twins with discordant phenotypes.

M C Vincent1, F Heitz, J Tricoire, G Bourrouillou, E Kuhlein, M Rolland, P Calvas.   

Abstract

22q11.2 deletion is a common genetic disorder characterised by a wide spectrum of clinical manifestations. To date no simple genotype-phenotype correlation has been established. Moreover, several reports have mentioned phenotypic discordance between monozygotic twins. No definite mechanism has been demonstrated and mosaicism, a postzygotic second hit, environmental effects and chance events have been proposed. The twinning process itself has been suspected in two cases (11, 23). We report the case of monozygous twins with a 22q11.2 deletion who are discordant for a heart defect. We found no arguments for mosaicism or twin-to-twin transfusion syndrome. The frequent discordance for heart defects in DiGeorge/Velo-cardio-facial syndromes (DGS/VCFS) does not favour the hypothesis of somatic mutations contributing to the phenotypic variation, but rather a complex interaction between genetic and environmental systems.

Entities:  

Mesh:

Year:  1999        PMID: 10191428

Source DB:  PubMed          Journal:  Genet Couns        ISSN: 1015-8146


  14 in total

1.  Clinical features of 78 adults with 22q11 Deletion Syndrome.

Authors:  Anne S Bassett; Eva W C Chow; Janice Husted; Rosanna Weksberg; Oana Caluseriu; Gary D Webb; Michael A Gatzoulis
Journal:  Am J Med Genet A       Date:  2005-11-01       Impact factor: 2.802

Review 2.  Insights into the genetic structure of congenital heart disease from human and murine studies on monogenic disorders.

Authors:  Terence Prendiville; Patrick Y Jay; William T Pu
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-01       Impact factor: 6.915

3.  Genetic factors are major determinants of phenotypic variability in a mouse model of the DiGeorge/del22q11 syndromes.

Authors:  I Taddei; M Morishima; T Huynh; E A Lindsay
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

4.  Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients.

Authors:  Tingwei Guo; Donna McDonald-McGinn; Anna Blonska; Alan Shanske; Anne S Bassett; Eva Chow; Mark Bowser; Molly Sheridan; Frits Beemer; Koen Devriendt; Ann Swillen; Jeroen Breckpot; Maria C Digilio; Bruno Marino; Bruno Dallapiccola; Courtney Carpenter; Xin Zheng; Jacob Johnson; Jonathan Chung; Anne Marie Higgins; Nicole Philip; Tony J Simon; Karlene Coleman; Damian Heine-Suner; Jordi Rosell; Wendy Kates; Marcella Devoto; Elizabeth Goldmuntz; Elaine Zackai; Tao Wang; Robert Shprintzen; Beverly Emanuel; Bernice Morrow
Journal:  Hum Mutat       Date:  2011-09-16       Impact factor: 4.878

Review 5.  DiGeorge syndrome/chromosome 22q11.2 deletion syndrome.

Authors:  K E Sullivan
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

Review 6.  Genetic counselling for schizophrenia in the era of molecular genetics.

Authors:  K A Hodgkinson; J Murphy; S O'Neill; L Brzustowicz; A S Bassett
Journal:  Can J Psychiatry       Date:  2001-03       Impact factor: 4.356

Review 7.  Common mechanisms in development and disease: BMP signaling in craniofacial development.

Authors:  Daniel Graf; Zeba Malik; Satoru Hayano; Yuji Mishina
Journal:  Cytokine Growth Factor Rev       Date:  2015-11-24       Impact factor: 7.638

8.  Decreased embryonic retinoic acid synthesis results in a DiGeorge syndrome phenotype in newborn mice.

Authors:  Julien Vermot; Karen Niederreither; Jean-Marie Garnier; Pierre Chambon; Pascal Dollé
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-31       Impact factor: 11.205

Review 9.  Molecular genetics of 22q11.2 deletion syndrome.

Authors:  Bernice E Morrow; Donna M McDonald-McGinn; Beverly S Emanuel; Joris R Vermeesch; Peter J Scambler
Journal:  Am J Med Genet A       Date:  2018-10       Impact factor: 2.802

10.  Biallelic expression of Tbx1 protects the embryo from developmental defects caused by increased receptor tyrosine kinase signaling.

Authors:  Subreena Simrick; Dorota Szumska; Jennifer R Gardiner; Kieran Jones; Karun Sagar; Bernice Morrow; Shoumo Bhattacharya; M Albert Basson
Journal:  Dev Dyn       Date:  2012-06-26       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.